IR-MED, INC
CIK 0001839133
Revenue (TTM)
—
Q2 Aug 2025
Net Income (TTM)
−$2.44M
+61.3% YoY
Q2 Aug 2025
EPS Diluted (TTM)
−$0.04
+57.1% YoY
Q2 Aug 2025
Gross Margin
—
Q2 Aug 2025
Operating Margin
—
Q2 Aug 2025
Net Margin
—
Q2 Aug 2025
Free Cash Flow (TTM)
−$2.12M
Q2 Aug 2025
Cash
$63K
Q2 Aug 2025
Total Debt
—
Q2 Aug 2025
Shares Outstanding
77.24M sh
Q2 Aug 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.